(S (NP-SBJ (NP (NN JNK)) (PRN (-LRB- -LRB-) (NP (NN c-Jun) (JJ NH2-terminal) (NN kinase)) (-RRB- -RRB-))) (VP (VBZ is) (NP-PRD (NP (DT a) (NN target)) (PP (IN for) (NP (NNS antioxidants)))) (PP (IN in) (NP (NN T) (NNS lymphocytes)))) (. .))
(S (NP-SBJ-1 (NN AP-1)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (NP-SBJ (-NONE- *-1)) (VP (TO to) (VP (VB behave) (PP (IN as) (NP (NP (DT a) (JJ redox-sensitive) (NN transcription) (NN factor)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*-2)) (VP (MD can) (VP (VB be) (VP (VBN activated) (NP (-NONE- *-3)) (PP (IN by) (NP-LGS (ADJP-COOD (CC both) (ADJP (JJ oxidant)) (CC and) (ADJP (JJ antioxidant))) (NNS stimuli)))))))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ (NP (DT the) (NNS mechanisms)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN AP-1))) (PP (IN by) (NP (NNS antioxidants))))))) (VP (VBP are) (ADJP-PRD (RB largely) (JJ unknown))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (NP-SBJ (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ (DT the) (ADJP (RB structurally) (JJ unrelated)) (JJ antioxidant) (NNS agents) (NP-COOD (NP (NP (NN pyrrolidine) (NN dithiocarbamate)) (PRN (-LRB- -LRB-) (NP (NN PDTC)) (-RRB- -RRB-))) (, ,) (NP (VBN butylated) (NN hydroxyanisole)) (, ,) (CC and) (NP (NN Nacetylcysteine)))) (VP (VBD activated) (NP (NP (NN JNK)) (PRN (-LRB- -LRB-) (NP (NN c-Jun) (JJ NH2-terminal) (NN kinase)) (-RRB- -RRB-))) (PP (IN in) (NP (NN Jurkat) (NN T) (NNS cells))))))) (. .))
(S (NP-SBJ (DT This) (NN activation)) (VP (VBD differed) (ADVP (RB substantially)) (PP (IN from) (NP (NP (DT that)) (VP-COOD (VP (VBN mediated) (NP (-NONE- *)) (PP (IN by) (NP-LGS-COOD (NP (NP (NN phorbol) (NN 12-myristate) (NN 13-acetate)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-))) (CC and) (NP (NN Ca2+) (NN ionophore))))) (CC or) (VP (VBN produced) (NP (-NONE- *)) (PP (IN by) (NP (NP (NN costimulation)) (PP (IN with) (NP (NP (NNS antibodies)) (PP (IN against) (NP (DT the) (NP-COOD (NP (ADJP (NN T) (NN cell) (NN receptor-CD3)) (NN complex)) (CC and) (TO to) (NP (NN CD28)))))))))))))) (. .))
(S-COOD (S (NP-SBJ (NP (DT The) (NN activation)) (PP (IN of) (NP (NN JNK))) (PP (IN by) (NP (JJ classical) (NN T) (NN cell) (NNS stimuli)))) (VP (VBD was) (ADJP-PRD (JJ transient)))) (, ,) (IN whereas) (S (NP-SBJ (NP (DT that)) (VP (VBN mediated) (NP (-NONE- *)) (PP (IN by) (NP-LGS-COOD (NP (NN PDTC)) (CC and) (NP (VBN butylated) (NN hydroxyanisole)) (-LRB- -LRB-) (CONJP (CC but) (RB not)) (NP (NN N-acetylcysteine)) (-RRB- -RRB-))))) (VP (VBD was) (ADJP-PRD (JJ sustained)))) (. .))
(S (NP-SBJ (NP (DT The) (NNS kinetics)) (PP (IN of) (NP (NN JNK) (NN activation)))) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN c-jun))) (SBAR (WHNP-4 (WDT which)) (S (NP-SBJ-5 (-NONE- *T*-4)) (VP-COOD (VP (VBD was) (ADJP-PRD-6 (JJ transient)) (PP-TMP-100 (IN after) (NP (NP (NN stimulation)) (PP (IN with) (NP-COOD (NP (NN PMA)) (CC plus) (NP (NN ionophore))))))) (CC and) (VP (VP=6 (VBD prolonged) (NP (-NONE- *-5)) (PP=100 (IN in) (NN response) (TO to) (NP (NN PDTC)))))))) (, ,) (SBAR (WHNP-7 (WDT which)) (S (NP-SBJ (-NONE- *T*-7)) (ADVP (RB also)) (VP (ADVP-TMP (RB transiently)) (VBD induced) (NP (NN c-fos)))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NP (NN JNK) (NN activation)) (PP (IN by) (NP-COOD (NP (NN PMA)) (CC plus) (NP (NN ionophore))))) (VP (VBD was) (ADJP-PRD (JJ sensitive) (PP (TO to) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NP (NN signaling) (NNS pathways)) (VP (VBG involving) (NP (NP-COOD (NP (NN Ca2+)) (, ,) (NP (NN protein) (NN kinase) (NN C)) (, ,) (CC and) (NP (NN tyrosine))) (NN phosphorylation))))) (, ,) (SBAR (WHNP-8 (WDT which)) (S (NP-SBJ-9 (-NONE- *T*-8)) (VP (VBD failed) (S (NP-SBJ (-NONE- *-9)) (VP (TO to) (VP (VB inhibit) (NP (NP (DT the) (NN activation)) (VP (VBN mediated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN PDTC))))))))))))))) (. .))
(S (NP-SBJ-COOD (NP (NP (NN Transfection)) (PP (IN of) (NP-COOD (NP (NP (JJ trans-dominant) (JJ negative) (NN expression) (NNS vectors)) (PP (IN of) (NP-COOD (NP (NN ras)) (CC and) (NP (NN raf))))) (, ,) (CONJP (RB together) (IN with)) (NP (JJ AP-1-dependent) (NN reporter) (NNS constructs))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN Western) (NN blot) (NN analysis)) (VP (VBG using) (NP (ADJP (JJ anti-ERK) (PRN (-LRB- -LRB-) (NP (JJ extracellular) (JJ signal-regulated) (NN kinase)) (-RRB- -RRB-))) (NNS antibodies)))) (, ,)) (VP (VBD indicated) (SBAR (IN that) (S (NP-SBJ-10 (DT the) (NN (ERK (Raf Ras))) (NN pathway)) (VP (VBD did) (RB not) (VP (VB appear) (S (NP-SBJ (-NONE- *-10)) (VP (TO to) (VP (VB mediate) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (DT the) (NN antioxidant)))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ (NP (DT the) (JJ combined) (NN treatment)) (PP (IN with) (NP (NP-COOD (NP (NN PDTC)) (CC and) (NP (NN PMA))) (, ,) (NP (NP (CD two) (NNS agents)) (SBAR (WHNP-11 (WDT that)) (S (NP-SBJ (-NONE- *T*-11)) (VP (VBP synergize) (PP-TMP (IN on) (NP (NN AP-1) (NN activation))))))) (, ,)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (JJ persistent) (NN phosphorylation)) (PP (IN of) (NP (NN ERK-2)))))) (. .))
(S (PP (IN In) (NP (NN conclusion))) (, ,) (NP-SBJ (PRP$ our) (NNS results)) (VP (VBP identify) (NP (NN JNK)) (PP (IN as) (NP (NP (DT a) (NN target)) (PP (IN of) (NP (JJ antioxidant) (NNS agents))) (SBAR (WHNP-12 (WDT which)) (S (NP-SBJ-13 (-NONE- *T*-12)) (VP (MD can) (VP (VB be) (VP (VBN regulated) (NP (-NONE- *-13)) (ADVP (RB differentially)) (PP (IN under) (NP (ADJP-COOD (ADJP (JJ oxidant)) (CC and) (ADJP (JJ antioxidant))) (NNS conditions))))))))))) (. .))
